ArticleOral oncology2016
Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer.
Article in Oral oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 34 citations in OpenAlex.
- Encouraging a Patient-Centred Approach to Education, Designing an eLearning Platform to Enhance Knowledge of HPV Positive Head and Neck Cancer: A Delphi Consensus Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026Article
- Bidirectional relationship between anxiety disorder and cancer: a longitudinal population-based cohort study.BMC cancer · 2025Article
- Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer.Psycho-oncology · 2024Article
- Head and neck cancer survivorship consensus statement from the American Head and Neck Society.Laryngoscope investigative otolaryngology · 2022Review
- Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.Oral oncology · 2021Article
- Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.Oral oncology · 2021Article
- Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.Oral oncology · 2019Article
- Article
- Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management.Current oncology (Toronto, Ont.) · 2019Review
- Treatment preferences in human papillomavirus-associated oropharyngeal cancer.Future oncology (London, England) · 2018Review
- Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.Cancer · 2018Article
- Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.Annals of oncology : official journal of the European Society for Medical Oncology · 2017Article
- Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.Cancer · 2017Article
- Dhikr Therapy for Reducing Anxiety in Cancer Patients.Asia-Pacific journal of oncology nursingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
Abstract
objectivesDiagnosis with an HPV-related oropharyngeal cancer includes unique social issues. However, it is unknown how common these psychosocial issues are for patients and whether they continue after treatment. MATERIALS AND
methodsPatients with pathologically confirmed HPV-positive oropharyngeal cancer (HPV-OPC, n=48) were recruited from two medical centers. Participants completed a computer assisted self interview that explored their psychosocial experiences during and after treatment. We examined responses overall and by age.
resultsThe majority of participants with confirmed HPV-OPC, reported being told that HPV could have (90%) or did cause (77%) their malignancy, but only 52% believed that HPV was the main cause of their OPC. Participants over 65years were less likely than younger participants to report that their doctors told them their tumor was HPV-positive (50% vs 84%, p=0.03). Anxiety that their tumor was HPV-related was a major issue among participants when first diagnosed (93%). However, only 17% still reported anxiety after treatment was complete. While many patients reported that providers discussed the emotional effects of diagnosis and treatment adequately (58%), almost half reported discussing these emotional effects inadequately (24%), or not at all (18%). Further, 18% reported that their families still wondered about some questions that they had never asked.
conclusionAfter treatment, some HPV-OPC patients remain concerned about HPV and have unanswered questions about HPV. Older patients had lower awareness of the role of HPV in their cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.